4-溴-2,5-二甲氧基苯乙胺(2C-B)临床毒理学:低至中等剂量与高剂量暴露后中毒严重程度
该前瞻性队列研究纳入2016至2018年荷兰毒物信息中心接诊的59例2C-B暴露患者,其中32例可随访。按报告剂量分为低至中等剂量(≤20 mg)、高剂量(>20 mg)和剂量未知组。两组中多数患者中毒严重程度为中等,常见症状包括瞳孔散大、激越或攻击行为、幻觉、意识模糊、焦虑、高血压和心动过速。作者结论为大多数2C-B中毒导致中等毒性,即使报告高剂量达192 mg也未观察到严重病例,临床病程通常短暂(不超过24小时),典型表现为幻觉伴轻度躯体效应。
要点
- 59例2C-B暴露患者中32例可随访,低至中等剂量(≤20 mg)9例(28%),高剂量(>20 mg)17例(53%),剂量未知6例(19%)。
- 低至中等剂量组和高剂量组中多数患者中毒严重程度均为中等,未观察到严重病例。
- 常见症状包括瞳孔散大、激越或攻击行为、幻觉、意识模糊、焦虑、高血压和心动过速。
- 报告高剂量可达192 mg,但未出现严重中毒病例。
- 临床病程通常短暂,不超过24小时,典型表现为幻觉伴轻度躯体效应。
适用人群与场景
- 2016至2018年因2C-B暴露向荷兰毒物信息中心咨询的患者,纳入前瞻性队列研究。
- 按报告2C-B剂量分为低至中等剂量(≤20 mg)、高剂量(>20 mg)和剂量未知组。
诊断标准与关键阈值
- 采用中毒严重程度评分(Poisoning Severity Score)对中毒严重程度进行分级。
- 通过液相/气相色谱-质谱法在剩余药物和生物样本中分析2C-B的存在。
研究设计与关键结果
- 研究类型为前瞻性队列研究,纳入59例患者,其中32例可随访。
- 低至中等剂量(≤20 mg)组9例(28%),高剂量(>20 mg)组17例(53%),剂量未知组6例(19%)。
- 低至中等剂量组和高剂量组中多数患者中毒严重程度为中等,未观察到严重病例。
- 常见症状包括瞳孔散大、激越或攻击行为、幻觉、意识模糊、焦虑、高血压和心动过速。
- 在5例患者中确认2C-B存在,其中尿液3例,药物样本4例。
- 报告高剂量可达192 mg,临床病程通常短暂(不超过24小时),典型表现为幻觉伴轻度躯体效应。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于2C-B暴露患者,即使报告剂量较高(如达192 mg),多数表现为中等毒性,病程通常不超过24小时,可据此进行病情告知和观察。
- 常见症状包括瞳孔散大、激越或攻击行为、幻觉、意识模糊、焦虑、高血压和心动过速,临床评估时应关注这些表现。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVE: We studied the severity of poisoning after exposure to low to moderate and high doses of 4-bromo-2,5-dimethoxyphenethylamine (2C-B).
METHODS: Patients for whom the Dutch Poisons Information Centre was consulted for 2C-B exposure from 2016 to 2018 were included in a prospective cohort study. Data were collected through telephone interviews with the physician or patient. Patients were categorized according to the reported 2C-B dose: low to moderate (up to 20 mg), high (greater than 20 mg), or unknown. Presence of 2C-B was analyzed in leftover drug and biological samples with liquid/gas chromatography-mass spectrometry. The severity of poisoning was graded with the Poisoning Severity Score.
RESULTS: We included 59 patients, of whom 32 could be followed up. Low to moderate 2C-B doses were reported by 9 patients (28%), high doses by 17 (53%), and unknown doses by 6 (19%). Poisoning was moderate in the majority of patients in both the low- to moderate-dose and high-dose groups. Frequently reported symptoms included mydriasis, agitation or aggression, hallucinations, confusion, anxiety, hypertension, and tachycardia. The presence of 2C-B was confirmed in 5 patients in urine (n=3) or drug samples (n=4).
CONCLUSION: In this study, most 2C-B poisonings resulted in moderate toxicity even at high reported doses up to 192 mg. No severe cases were observed. The clinical course was usually short-lived (up to 24 hours) and typically involved hallucinations in addition to mild somatic effects.
参考来源
- Nugteren-van Lonkhuyzen JJ, de Lange DW, van Riel AJHP, et al. The Clinical Toxicology of 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): The Severity of Poisoning After Exposure to Low to Moderate and High Doses. Ann Emerg Med. 2020. PMID: 32507489. doi:10.1016/j.annemergmed.2020.04.022
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。